Stockreport

Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference

Inozyme Pharma, Inc.  (INZY) 
PDF BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innov [Read more]